New research suggests that a procedure now regarded as Plan B when patients have episodes of rapid heartbeat after a heart ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

From its cardiovascular divisions, Medtronic brought in $3.1 billion for an increase of 6.1%—driven in part by the launches ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...